A meta-analysis of the Val158Met COMT polymorphism and violent behavior in Schizophrenia

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Singh, Jay P ^a   Volavka, Jan ^b   Czobor, Pál ^c,d   van Dorn, Richard A ^a,e  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CATECHOL METHYLTRANSFERASE GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RISK ASSESSMENT; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VIOLENCE;

ADULT; AGGRESSION; ALLELES; BEHAVIOR; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; ODDS RATIO; PHARMACOGENETICS; POLYMORPHISM, GENETIC; RISK; ROC CURVE; SCHIZOPHRENIA; SEX FACTORS; VIOLENCE;

EID: 84865055429     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043423     Document Type: Article

References (64)

1. Fazel S, Gulati G, Linsell L, Geddes JR, Grann M, (2009) Schizophrenia and violence: Systematic review and meta-analysis. PLoS Med 6: e1000120.
2. Volavka J (2002) Neurobiology of violence. Washington, DC: American Psychiatric Publishing.
3. Siever LJ, (2008) Neurobiology of aggression and violence. Am J Psychiatry 165: 429-442.
4. Comai S, Tau M, Gobbi G, (2012) The psychopharmacology of aggressive behavior: A translational approach: Part 1: Neurobiology. J Clin Psychopharmacol 32: 83-94.
5. Allan ER, Alpert M, Sison CE, Citrome L, Laury G, et al. (1996) Adjunctive nadolol in the treatment of acutely aggressive schizophrenic patients. J Clin Psychiatry 57: 455-459.
6. Silver JM, Yudofsky SC, Slater JA, Gold RK, Stryer BLK, et al. (1999) Propranolol treatment of chronically hospitalized aggressive patients. J Neuropsychiatry Clin Neurosci 11: 328-335.
7. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, et al. (1996) Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6: 243-250.
8. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, et al. (1998) Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95: 9991-9996.
9. Fernandes C, Paya-Cano JL, Sluyter F, D'Souza U, Plomin R, et al. (2004) Hippocampal gene expression profiling across eight mouse inbred strains: Towards understanding the molecular basis for behaviour. Eur J Neurosci 19: 2576-2582.
10. Strous RD, Bark N, Parsia SS, Volavka J, Lachman HM, (1997) Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: Evidence for association with aggressive and antisocial behavior. Psychiatry Res 69: 71-77.
11. Strous RD, Bark N, Woerner M, Lachman HM, (1997) Lack of association of a functional cathechol-O-methyltransferase gene polymorphism in schizophrenia. Biol Psychiatry 41: 493-495.
12. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med 6: e1000097.
13. Koen L, Kinnear CJ, Corfield VA, Emsley RA, Jordaan E, et al. (2004) Violence in male patients with schizophrenia: Risk markers in a South African population. Aust NZ J Psychiatry 38: 254-259.
14. Landis JR, Koch GG, (1977) The measurement of observer agreement for categorical data. Biometrics 33: 159-174.
15. Deeks JJ, Bossuyt PM, Gatsonis C (2010) Cochrane handbook for systematic reviews of diagnostic test accuracy. Chichester, UK: Cochrane Collaboration.
16. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, et al. (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58: 982-990.
17. Rutter CM, Gatsonis CA, (2001) A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20: 2865-2884.
18. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PMM, (2003) The diagnostic odds ratio: A single indicator of test performance. J Clin Epidemiol 56: 1129-1135.
19. Higgins J, Thompson S, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
20. Tovilla-Zarate C, Juarez-Rojop I, Ramon-Frias T, Villar-Soto M, Pool-Garcia S, et al. (2011) No association between COMT val158met polymorphism and suicidal behavior: Meta-analysis and new data. BMC Psychiatry 11: 151-159.
21. Munafo M, Matheson I, Flint J, (2007) Association of the DRD2 gene Taq1A polymorphism and alcoholism: A meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry 12: 454-461.
22. Kim-Cohen J, Caspi A, Taylor A, Williams B, Newcombe R, et al. (2006) MAOA, maltreatment, and gene-environment interaction predicting children's mental health: New evidence and a meta-analysis. Mol Psychiatry 11: 903-913.
23. Han DH, Kee BS, Min KJ, Lee YS, Na C, et al. (2006) Effects of catechol-O-methyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients. Clin Neurosci Neuropathol 17: 95-99.
24. Han DH, Park DB, Na C, Kee BS, Lee YS, (2004) Association of aggressive behavior in Korean male schizophrenic patients with polymorphisms in the serotonin transporter promoter and catecholamine-O-methyltransferase genes. Psychiatry Res 129: 29-37.
25. Costas J, Sanjuan J, Ramos-Rios R, Paz E, Agra S, et al. (2011) Heterozygosity at catechol-O-methyltransferase Val158Met and schizophrenia: New data and meta-analysis. J Psychiatr Res 45: 7-14.
26. Barnett JH, Jones PB, Robbins TW, Mueller U, (2007) Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: A meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Molec Psychiatry 12: 502-509.
27. Thompson SG, Higgins J, (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559-1573.
28. Ioannidis JP, Patsopoulos NA, Evangelous E, (2007) Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335: 914-916.
29. Rothstein HR, Sutton AJ, Borenstein M (2005) Publication bias in meta-analysis: Prevention, assessment and adjustments. New York, NY: Wiley.
30. Harbord RM, Egger M, Sterne JAC, (2006) A modified test for small study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25: 3443-3457.
31. Xiong H, Wong H, Nan JLR, Akira DR, Ruizhen C, et al. (2010) Association of the COMT gene polymorphism and schizophrenia violent attacks. Guangdong Med J 31: 82-83.
32. Kim YR, Kim JH, Kim SJ, Lee D, Min SK, (2008) Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population. Eur Neuropsychopharmacol 18: 820-825.
33. Tosato S, Bonetto C, Di Forti M, Collier D, Cristofalo D, et al. (2011) Effect of COMT genotype on aggressive behaviour in a community cohort of schizophrenic patients. Neurosci Lett 495: 17-21.
34. Higgins J, Thompson S, Deeks J, Altman D, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
35. Soyka M, (2011) Neurobiology of aggression and violence in schizophrenia. Schizophr Bull 37: 913-920.
36. Volavka J, Citrome L, (2011) Pathways to aggression in schizophrenia affect results of treatment. Schizophr Bull 37: 921-929.
37. Thompson JM, Sonuga-Barke EJ, Morgan AR, Cornforth CM, Turic D, et al. (2012) The catechol-O-methyltransferase (COMT) Val158Met polymorphism moderates the effect of antenatal stress on childhood behavioural problems: Longitudinal evidence across multiple ages. Dev Med Child Neurol 54: 148-154.
38. Hodgins S, Tiihonen J, Ross D, (2005) The consequences of Conduct Disorder for males who develop schizophrenia: Associations with criminality, aggressive behavior, substance use, and psychiatric services. Schizophr Res 78: 323-335.
39. Swanson JW, Van Dorn RA, Swartz MS, Smith A, Elbogen EB, et al. (2008) Alternative pathways to violence in persons with schizophrenia: The role of childhood antisocial behavior problems. Law Hum Behav 32: 228-240.
40. Collip D, Van WR, Peerbooms O, Lataster T, Thewissen V, et al. (2011) COMT Val158Met-stress interaction in psychosis: Role of background psychosis risk. CNS Neurosci Ther 17: 612-619.
41. Fazel S, Grann M, Cårlström E, Lichtenstein P, Långström N, (2009) Risk factors for violent crime in schizophrenia: A national cohort study of 13,806 patients. J Clin Psychiatry 70: 362-369.
42. Iancu I, Bodner E, Roitman S, Piccone SA, Poreh A, et al. (2010) Impulsivity, aggression and suicide risk among male schizophrenia patients. Psychopathology 43: 223-229.
43. Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, et al. (2003) Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 60: 82-91.
44. Volavka J, Swanson JW, Citrome LL (2012) Understanding and managing violence in schizophrenia. In: Lieberman JA, Murray RM, editors. Comprehensive care of schizophrenia: A textbook of clinical management. New York, NY: Oxford University Press. 262-290.
45. Nolan KA, Volavka J, Czobor P, Cseh A, Lachman H, et al. (2000) Suicidal behavior in patients with schizophrenia is related to COMT polymorphism. Psychiatr Genet 10: 117-124.
46. Nedic G, Nikolac M, Sviglin KN, Muck-Seler D, Borovecki F, et al. (2011) Association study of a functional catechol-O-methyltransferase (COMT) Val108/158Met polymorphism and suicide attempts in patients with alcohol dependence. Int J Neuropsychopharmacol 14: 377-388.
47. Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, et al. (2009) The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 70: 1-46.
48. Alia-Klein N, O'Rourke TM, Goldstein RZ, Malaspina D, (2007) Insight into illness and adherence to psychotropic medications are separately associated with violence severity in a forensic sample. Aggress Behav 33: 86-96.
49. Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, et al. (2006) Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry 67: 453-460.
50. Swartz MS, Swanson JW, Hiday VA, Borum R, Wagner R, et al. (1998) Taking the wrong drugs: The role of substance abuse and medication noncompliance in violence among severely mentally ill individuals. Soc Psychiatry Psychiatr Epidem 33: S75-S80.
51. Fazel S, Långström N, Hjern A, Grann M, Lichtenstein P, (2009) Schizophrenia, substance abuse, and violent crime. JAMA 301: 2016-2023.
52. Hong JP, Lee JS, Chung S, Jung J, Yoo HK, et al. (2008) New functional single nucleotide polymorphism (Ala72Ser) in the COMT gene is associated with aggressive behavior in male schizophrenia. Am J Med Genet B 147: 658-660.
53. Volavka J (2012) Clozapine is gold standard, but questions remain. Int J Neuropsychopharmacol: doi:10.1017/S1461145712000284.
54. Nolan KA, Czobor P, Roy BB, Platt MM, Shope CB, et al. (2003) Characteristics of assaultive behavior among psychiatric inpatients. Psychiatr Serv 54: 1012-1016.
55. Gu Y, Yun L, Tian Y, Hu Z, (2009) Association between COMT gene and Chinese male schizophrenic patients with violent behavior. Med Sci Monit 15: 484-489.
56. Jones G, Zammit S, Norton N, Hamshere ML, Jones SJ, et al. (2001) Aggressive behaviour in patients with schizophrenia is associated with catechol-O-methyltransferase genotype. Br J Psychiatry 179: 351-355.
57. Koh KB, Choi EH, Lee YJ, Han M, Choi SS, et al. (2011) The relation of serotonin-related gene and COMT gene polymorphisms with criminal behavior in schizophrenia disorder. J Clin Psychiatry 73: 159-163.
58. Kotler M, Barak P, Cohen H, Averbuch IE, Grinshpoon A, et al. (1999) Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Am J Med Genet 88: 628-633.
59. Liou YJ, Tsai SJ, Hong CJ, Wang YC, Lai IC, (2001) Association analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenic patients in Taiwan. Neuropsychobiology 43: 11-14.
60. Park TW, Yoon KS, Kim JH, Park WY, Hirvonen A, et al. (2002) Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia. Eur Neuropsychopharmacol 12: 299-303.
61. Strous RD, Nolan KA, Lapidus R, Diaz L, Saito T, et al. (2003) Aggressive behavior in schizophrenia is associated with the low activity COMT polymorphism: A replication study. Am J Med Genet B 120: 29-34.
62. Zammit S, Jones G, Jones SJ, Norton N, Sanders RD, et al. (2004) Polymorphisms in the MAOA, MAOB, and COMT genes and aggressive behavior in schizophrenia. Am J Med Genet B 128: 19-20.
63. Yudofsky SC, Silver JM, Jackson W, Endicott J, (1986) The overt aggression scale for the objective rating of verbal and physical aggression. Am J Psychiatry 143: 35-39.
64. Kay SR, Wolkenfelf F, Murrill LM, (1988) Profiles of aggression among psychiatric patients. J Nerv Ment Dis 176: 539-554.